首页> 美国卫生研究院文献>Antioxidants Redox Signaling >Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects
【2h】

Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects

机译:俄歇电子对细胞膜的局部照射通过氧化应激介导的非靶向作用具有细胞毒性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aims: We investigated whether radiation-induced nontargeted effects are involved in the cytotoxic effects of anticell surface monoclonal antibodies labeled with Auger electron emitters, such as iodine 125 (monoclonal antibodies labeled with 125I [125I-mAbs]). >Results: We showed that the cytotoxicity of 125I-mAbs targeting the cell membrane of p53+/+ HCT116 colon cancer cells is mainly due to nontargeted effects. Targeted and nontargeted cytotoxicities were inhibited in vitro following lipid raft disruption with Methyl-β-cyclodextrin (MBCD) or filipin or use of radical oxygen species scavengers. 125I-mAb efficacy was associated with acid sphingomyelinase activation and modulated through activation of the AKT, extracellular signal-related kinase ½ (ERK1/2), p38 kinase, c-Jun N-terminal kinase (JNK) signaling pathways, and also of phospholipase C-γ (PLC-γ), proline-rich tyrosine kinase 2 (PYK-2), and paxillin, involved in Ca2+ fluxes. Moreover, the nontargeted response induced by directing 5-[(125)I]iodo-2′-deoxyuridine to the nucleus was comparable to that of 125I-mAb against cell surface receptors. In vivo, we found that the statistical significance of tumor growth delay induced by 125I-mAb was removed after MBCD treatment and observed oxidative DNA damage beyond the expected Auger electron range. These results suggest the involvement of nontargeted effects in vivo also. >Innovation: Low-energy Auger electrons, such as those emitted by 125I, have a short tissue range and are usually targeted to the nucleus to maximize their cytotoxicity. In this study, we show that targeting the cancer cell surface with 125I-mAbs produces a lipid raft-mediated nontargeted response that compensates for the inferior efficacy of non-nuclear targeting. >Conclusion: Our findings describe the mechanisms involved in the efficacy of 125I-mAbs targeting the cancer cell surface. Antioxid. Redox Signal. 25, 467–484.
机译:>目标:我们研究了辐射诱导的非靶向效应是否参与了俄歇电子发射器标记的抗细胞表面单克隆抗体的细胞毒性作用,如碘125(单克隆抗体标记为 125 I [ 125 I-mAbs])。 >结果:我们发现针对p53 + / + HCT116结肠癌细胞膜的 125 I-mAbs的细胞毒性主要是由于非目标效果。在用甲基-β-环糊精(MBCD)或菲林破坏脂筏或使用自由基氧清除剂后,体外抑制了靶向和非靶向的细胞毒性。 125 I-mAb的功效与酸性鞘磷脂酶的激活有关,并通过AKT,细胞外信号相关激酶½(ERK1 / 2),p38激酶,c-Jun N-末端激酶(JNK)的激活来调节)的信号通路,以及磷脂酶C-γ(PLC-γ),富含脯氨酸的酪氨酸激酶2(PYK-2)和paxillin参与Ca 2 + 通量。此外,将5-[((125)I] iodo-2'-deoxyuridine)导入细胞核所诱导的非靶向反应与针对细胞表面受体的 125 I-mAb相当。在体内,我们发现MBCD处理后去除了 125 I-mAb诱导的肿瘤生长延迟的统计学意义,并且观察到氧化DNA损伤超出了预期的俄歇电子范围。这些结果表明体内也有非靶向作用。 >创新:低能量俄歇电子(例如 125 I发射的电子)具有较短的组织范围,通常针对核,以最大化其细胞毒性。在这项研究中,我们显示了以 125 I-mAbs靶向癌细胞表面会产生脂质筏介导的非靶向反应,从而弥补了非核靶向的劣等功效。 >结论:我们的发现描述了靶向癌细胞表面的 125 I-mAb的功效所涉及的机制。抗氧化。氧化还原信号。 25,467–484。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号